Chicago, IL and White Plains, NY – October 4, 2022
Waud Capital Partners (“WCP”), a growth-oriented private equity firm, today announced the closing of a single-asset continuation fund in connection with the recapitalization of its portfolio company Ivy Rehab Physical Therapy (“Ivy” or the “Company”). Ivy is a leading provider of outpatient therapy services across the Northeast, Mid-Atlantic, Southeast, and Midwest regions of the United States through a rapidly growing network of more than 450 clinics that includes approximately 100 dedicated pediatric therapy clinics. The continuation fund, sponsored by WCP, has been supported by new and returning limited partners and is anchored by funds managed by Morgan Stanley Private Equity Secondaries Team, an investment team within Morgan Stanley Investment Management. WCP, its existing limited partners, and Ivy management reinvested significant proceeds into the continuation fund as part of the transaction.
Ivy has grown its clinic base and revenue more than tenfold since WCP’s initial investment in 2016. The Company has pursued growth organically by opening new locations and expanding service lines and inorganically through add-on acquisitions to build density in existing markets and to expand into new geographies. Ivy is led by CEO Michael Rucker, and he and the experienced executive leadership team recruited by WCP will remain with the company over its new investment horizon in an effort to pursue additional growth and industry leadership. Michael Rucker, CEO of Ivy, stated, “Since initially partnering with WCP, Ivy advanced from being the 25th to the 5th largest outpatient therapy services provider in the United States. WCP has been a supportive partner, making significant contributions to Ivy through strategic planning and proactive resourcing. I couldn’t be more pleased to continue my relationship with WCP over the years ahead as we work to be an industry leader in growth, quality of patient care, and teammate satisfaction.”
Reeve B. Waud, Managing Partner and Founder of WCP, commented, “We are thrilled by the tremendous support from our new and existing limited partners for this continuation fund, which provides Ivy additional capital and time to support meaningful value creation as Ivy continues to execute on its demonstrated, multi-pronged growth strategy.”
David O. Neighbours, Partner of WCP and deal lead for the Ivy investment, commented, “We look forward to extending our longstanding partnership with Michael Rucker and the rest of the Ivy executive leadership team as we work to build the preeminent industry innovator in the therapy services market. We believe Ivy is well-positioned to build upon the success achieved to date.”
Harris Williams served as financial advisor, Aviditi Advisors served as continuation fund advisor, and Kirkland & Ellis LLP served as legal counsel for WCP and Ivy.
About Waud Capital Partners
Waud Capital Partners is a growth-oriented private equity firm with total capital commitments of approximately $3.7 billion since its founding in 1993. WCP seeks to partner with strong management teams to build market-leading companies within two industries: healthcare services and software/technology. Since its founding, WCP has successfully completed more than 400 investments, including platform companies and follow-on opportunities. To learn more, visit www.waudcapital.com.
About Morgan Stanley Private Equity Secondaries
Morgan Stanley Private Equity Secondaries, an investment team within Morgan Stanley Investment Management, seeks to deliver innovative private market solutions to a global client base. As part of a broader team of 50 dedicated private markets focused professionals, the secondaries business draws on decades of investment experience across private markets. For further information about Morgan Stanley Private Equity Secondaries, visit www.morganstanley.com/im. www.morganstanley.com/im.
About Ivy Rehab Physical Therapy
Ivy is a leading provider of outpatient therapy services across the Northeast, Mid-Atlantic, Southeast, and Midwest regions of the United States through a rapidly growing network of more than 450 clinics that includes approximately 100 dedicated pediatric therapy clinics. Across its network of sites, Ivy offers a comprehensive set of therapy treatment options and specialized care programs and is dedicated to providing exceptional clinical care and the best patient experience. For additional information on Ivy,visit ivyrehab.com.
FINRA BrokerCheck. Investors may check the background of their Investment Professional by contacting the Financial IndustryRegulatory Authority (FINRA). FINRA BrokerCheck is a free tool to help investors check the professional background of current andformer FINRA-registered securities firms and brokers. FINRA BrokerCheck is available by calling 1-800-289-9999 and at www.FINRA.org. The FINRA BrokerCheck brochure describing this program is available to investors at www.FINRA.org.
To report a website vulnerability, please go to Responsible Disclosure.
Eaton Vance, Atlanta Capital, Parametric and Calvert are part of Morgan Stanley Investment Management. Morgan Stanley Investment Management is the asset management division of Morgan Stanley.
MSIM, the asset management division of Morgan Stanley (NYSE: MS), and its affiliates have arrangements in place to market each other’s products and services. Each MSIM affiliate is regulated as appropriate in the jurisdiction it operates. MSIM’s affiliates are: Eaton Vance Management (International) Limited, Eaton Vance Advisers International Ltd, Calvert Research and Management, Eaton Vance Management, Parametric Portfolio Associates LLC, and Atlanta Capital Management LLC.
For USA PATRIOT Act Disclosure Notice please click here.
This image indicates content designed specifically for Financial Advisors / Investment Professionals. This material is not to be used with the public.
Before investing in any Eaton Vance, Calvert or Morgan Stanley Investment Management Inc.-advised fund, prospective investors should consider carefully the investment objective(s), risks, and charges and expenses. Read the prospectus carefully before you invest or send money. For open-end mutual funds, the current prospectus contains this and other information. To obtain an open-end mutual fund prospectus or summary prospectus and the most recent annual and semiannual shareholder reports, contact your financial advisor or download a copy here. For closed-end funds, you should contact your financial advisor. To obtain the most recent annual and semi-annual shareholder report for a closed-end fund contact your financial advisor or download a copy here. To obtain an exchange-traded fund, ("ETF") prospectus or summary prospectus, contact your financial advisor or download a copy here.
Before purchasing any variable product, consider the objectives, risks, charges, and expenses associated with the underlying investment option(s) and those of the product itself. For a prospectus containing this and other information, contact your investment or insurance professional. Read the prospectus carefully before investing.
Morgan Stanley Investment Management does not provide tax or legal advice. Prospective investors should consult with a tax or legal advisor before making any investment decision. The information on this Web page is for U.S. residents only and does not constitute an offer to sell, or a solicitation of an offer to purchase, securities in any jurisdiction to any person to whom it is not lawful to make such an offer.
© Eaton Vance Management. All rights reserved.
Morgan Stanley Distribution, Inc. serves as the distributor for Morgan Stanley Funds. Morgan Stanley Distribution, Inc. Member FINRA / SIPC. Eaton Vance open-end mutual funds are offered through Eaton Vance Distributors, Inc. One Post Office Square, Boston, MA 02109. Member FINRA/SIPC. Exchange-traded funds are distributed by Foreside Fund Services, LLC.
NOT FDIC INSURED | OFFER NO BANK GUARANTEE | MAY LOSE VALUE | NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY | NOT A DEPOSIT